Veracyte Inc expected to post a loss of 15 cents a share - Earnings Preview

Veracyte

04/11/2023 02:15

* Veracyte Inc  VCYT.OQ   VCYT.O  is expected to show a rise
in
quarterly revenue when it reports  results 
    * The South San Francisco California-based  company is
expected to
report  a 11.6% increase in revenue to $84.384 million from
$75.59 million a year ago, according to the mean estimate from 8
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Veracyte Inc is for
a
loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Veracyte
Inc is
$34.5​, above​ its last closing price of $24.46. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.15       -0.15      -0.12     Beat    21.4
 Mar. 31 2023  -0.15       -0.13      -0.11     Beat    17.8
 Dec. 31 2022  -0.15       -0.15      -0.05     Beat    67​
 Sep. 30 2022  -0.24       -0.25      -0.12     Beat    51.7
 ​​Jun.        -0.22       -0.22      -0.13     Beat    40.5
 30 2022                                                
 Mar. 31 2022  -0.24       -0.24      -0.20     Beat    15.9​
 Dec. 31 2021  -0.18       -0.16      -0.15     Beat    6.9
 Sep. 30 2021  -0.17       -0.16      -0.20     Missed  -21.2
 This summary was machine generated November 4 at 02:15 GMT.  All
figures in US dollars  unless otherwise stated